Jane Myles

Jane Myles has a diverse work experience in the clinical research field. Jane currently holds the position of Strategic Advisor at Curebase and was previously the Chairperson of the Strategic Advisory Board at the same company. Prior to that, they served as the VP of Clinical Trial Innovation.

Jane also has experience working at the Decentralized Trials & Research Alliance (DTRA) as a Program Director and as the Co-Lead of Priority Initiative 3B, DCT Playbook.

Before joining Curebase and DTRA, Jane founded their own company, jemTech LLC, where they served as the Founder and Owner.

Earlier in their career, Jane worked at Covance as the Director of Decentralized Trials, where they led the design and optimization of the decentralized trials delivery process.

Jane also held various roles at Roche, including the Former Head of Operational Intelligence and Innovation and Global Head of Patient Recruitment. At Roche, they focused on optimizing patient recruitment, implementing innovative approaches, and improving study delivery timelines.

Jane's career in clinical operations began at Genentech, where they held positions such as Associate Director of Clinical Operations and Sr. Manager of Clinical Trial Management.

Jane Myles holds a BSc(Hon) degree in Life Sciences from Queen's University and an MSc degree in Pharmacology and Toxicology, also from Queen's University.